Year: 2021

news_6

Celltrion Healthcare receives European Commission (EC) approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, YuflymaTM (CT-P17)

Yuflyma™ (CT-P17) is the first adalimumab biosimilar with a high concentration, low-volume and citrate-free formulation; 60% of adalimumab market captured...

news_6

Asia-Pacific $225+ Billion Pharmaceutical Contract Research Organization (CRO) Market to 2030 by Service, Therapeutic Application, End User, and Country – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast...

news_6

India eRickshaw Market Report 2020-2025: Government Policies Supporting the Distribution and Charging of Li-ion Batteries to Spur Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Government Policies Supporting the Distribution and Charging of Li-ion Batteries to Spur Growth of the Indian eRickshaw Market,...